Moderna Spikevax gets full USFDA nod for kids 6 months through 11 years at increased COVID risk Ruchika Sharma13 July 2025 3:30 PM ISTCambridge: Moderna has received approval from the U.S. Food and Drug Administration (FDA) for the supplemental Biologics License Application...
Moderna gets USFDA nod for RSV Vaccine mRESVIA in adults aged 18-59 at increased risk for RSV disease Ruchika Sharma13 Jun 2025 11:49 AM ISTCambridge: Moderna, Inc. has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for mRESVIA...
Moderna bags Health Canada nod for RSV vaccine for adults aged 60 years and older Ruchika Sharma11 Nov 2024 4:43 PM ISTCambridge: Moderna, Inc. has announced Health Canada has approved mRESVIA (Respiratory Syncytial Virus mRNA vaccine) for active immunization for...
London HC decision fuels continued legal battle between Pfizer, Moderna over COVID vaccine patents Ruchika Sharma4 July 2024 4:10 PM ISTLondon: Pfizer and Moderna's legal dispute over their competing COVID-19 vaccines is poised to persist following a mixed ruling from London's...
Moderna files FDA application for JN.1 targeting COVID vaccine Ruchika Sharma11 Jun 2024 10:30 AM ISTCambridge: Moderna, Inc. has announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its...
Moderna gets USFDA nod for mRNA RSV vaccine Ruchika Sharma2 Jun 2024 1:30 PM ISTCambridge: Moderna, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory...
COVID vaccine: Moderna wins patent case in Europe against Pfizer, BioNTech Ruchika Sharma19 May 2024 1:00 PM ISTLondon: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and BioNTech concerning...
Bayer Healthcare backed Metagenomi cuts US IPO valuation target to USD 563 million Ruchika Sharma11 Feb 2024 1:30 PM ISTNew Delhi: Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its U.S. initial...
Moderna jumps on Oppenheimer upgrade, 2025 sales growth goal Ruchika Sharma3 Jan 2024 9:00 AM ISTAccording to Oppenheimer, Moderna could have five products on the market by 2026.
Melanoma vaccine could be available by 2025: Moderna CEO Ruchika Sharma17 Dec 2023 1:00 PM ISTWashington: Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two...
Moderna updated COVID vaccine approved by UK regulator Ruchika Sharma17 Sept 2023 11:30 AM ISTUnited Kingdom: The UK drug regulator has said it has approved an updated COVID-19 vaccine by Moderna, making it the second shot to be used in the...
Moderna receives USFDA nod for updated COVID vaccine Ruchika Sharma13 Sept 2023 11:40 AM ISTCambridge: Moderna, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application(sBLA)...
